Illicit drug production poses a growing threat to public health and security in Europe. Monitoring drug precursor markets helps detect emerging risks and enables timely EU-level responses to disrupt supply and prevent diversion and trafficking into illicit drug production. Today, the EUDA has published nine reports resulting from the first ever precursor assessments conducted at EU…
Čtěte více
How can Europe prepare for the impact of emerging technologies in the drugs field and their implications for public health and security? This question will be at the heart of our 'Technology foresight for EU security and resilience' workshop taking place in Lisbon from 11–12 February. The meeting will explore how technological change might influence drug production and supply, consumption patterns, responses and surveillance capacity, and how policymakers can act early to strengthen preparedness and resilience.
The two-day workshop is one of the EUDA’s flagship strategic foresight activities…
Čtěte více
New EU legal measures, which entered into force this month, will see three harmful new psychoactive substances (NPS) brought under control across the EU. The substances — all new synthetic cathinones — are: 2-methylmethcathinone (2-MMC), 4-bromomethcathinone (4-BMC) and N-ethylnorpentedrone (NEP). These are now classified as controlled ‘drugs’ under EU law.
The decision to control the substances was introduced by the European Commission last year through a Delegated Directive, amending the existing legal framework designed to bring a stronger and faster response to NPS in Europe (1). The…
Čtěte více
